SCIENTIFIC PRESENTATIONS & PUBLICATIONS
EASD
September 15-19, 2025
MET-233 is a differentiated efficacious amylin analogue in preclinical studies, combinable with MET-097, an ultra-long acting GLP-1 receptor agonist
Oral presentation Paris Hall, Friday Sept 19 10.00-11.00, Session OP 38 New drugs on the horizon?
Metsera, Inc., New York, NY and London, UK
Presenter
James Minion
Poster #
224
Classification
Nonclinical